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266Background: Patients requiring extracorporeal membrane oxygenation (ECMO) support after a Norwood
operation constitute an extremely high-risk group. Data regarding risk factors for the requirement for ECMO
post-Norwood are limited, however. We retrospectively assessed risk factors for requiring ECMO support after
a Norwood operation during a 10-year period in a high-volume center.
Methods:Retrospective case-control study of 64 consecutive patients requiring ECMO support after a Norwood
operation at a single institution during a 10-year period (January 2001-December 2010), with a 3:1 era-matched
control group of patients who underwent a Norwood but did not require ECMO.
Results: Inunivariate analysis, ascending aorta less than2.0mm, longer cardiopulmonarybypass (CPB) time, intra-
operative shunt revision, and right ventricle to pulmonary artery conduit were associatedwith the need for postope-
rative ECMO. A single left ventricle was protective compared with single right ventricle anatomy. By multivariate
logistic regression, birth weight less than 2.5 kg and longer CPB timewere independently associated with the need
for postoperative ECMO.Receiver-operating characteristic curve analysis identified a peak lactate of 9mmol/L and
a peak vasoactive inotrope score (VIS) of 27 within 48 hours of surgery as most prognostic of the need for ECMO.
Conclusions: Birth weight less than 2.5 kg and longer CPB time are independently associated with the need for
ECMO after a Norwood operation. Peak serum lactate and peak VIS may be useful in stratifying risk for ECMO.
Risk factors for ECMO post-Norwood appear to be similar to the risk factors for early mortality post-Norwood.
(J Thorac Cardiovasc Surg 2014;148:266-72)The subset of patients who require mechanical circulatory
support after a Norwood operation constitutes an extremely
high-risk population. Several groups have reported hospital
survival between 30% and 40% for these patients,1-3 with
approximately 25% transplant-free survival at 2 years.4
The data regarding risk factors for requiring extracorporeal
membrane oxygenation (ECMO) after a Norwood opera-
tion are limited, however. To identify factors associated
with the need for ECMO after a Norwood, we performed
a retrospective case-control study comparing 64 patients
who needed ECMO support after a Norwood operation
during a 10-year period at a single high-volume surgical
center with a 3:1 era-matched group of control patients
who received a Norwood operation but did not require
ECMO postoperatively. Preoperative, intraoperative, and
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The Journal of Thoracic and Cardiovascular Surgidentify those factors associated with the requirement for
mechanical support in the postoperative period.METHODS
Study Design
We performed a retrospective case-control study of all single-ventricle
patients who required ECMO support before hospital discharge after a
Norwood operation (identified for the purpose of this study as Damus-
Kaye-Stansel anastomosis and systemic-to-pulmonary artery shunt, with or
without arch reconstruction) at the University of Michigan (Ann Arbor) du-
ring a 10-year period, from January 2001 to December 2010, with a 3:1 era-
matched (6 months) control group of patients who underwent a Norwood
but did not require ECMO support. The size of the control group was based
on a power analysis demonstrating that 3:1 matching would provide greater
than 80% power to detect an odds ratio of at least 2.5 at the .05 significance
level. Clinical data on this cohort of patients were present in an existing
database. Patients requiring ECMO preoperatively and patients undergoing
hybrid stage 1 palliation were excluded from analysis. The study was
approved by the University of Michigan Institutional Review Board.
Demographic and preoperative variables, including sex, ethnicity, birth
weight, prematurity (<37 weeks’ gestation), age at operation, lactate (peak
and immediately before surgery), renal function (blood urea nitrogen and
creatinine), presence of any extracardiac anomalies, cardiac diagnosis,
and the presence of a restrictive atrial septum requiring intervention were
collected on cases (n ¼ 64) and controls (n ¼ 191). Additional data from
the preoperative echocardiogram (echo), including the degree of atrioven-
tricular valve regurgitation, systemic ventricular systolic function, and
ascending aorta size, were also collected. The intraoperative data included
shunt type, requirement for intraoperative shunt revision, and cardiopulmo-
nary bypass parameters. Postoperative variables analyzed included peak
lactate, peak vasoactive-inotropic score (VIS),5 and mean arterial pO2.
Blood lactate levels and peak VIS were collected for the initial 48 hoursery c July 2014
Abbreviations and Acronyms
AOR ¼ adjusted odds ratio
AUC ¼ area under the curve
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
ECMO ¼ extracorporeal membrane oxygenation
HCA ¼ hypothermic circulatory arrest
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NPV ¼ negative predictive value
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Dfor all controls. For the ECMO cases, blood lactate and VIS were analyzed
for up to 48 hours or until ECMO cannulation or cardiac arrest, whichever
came first. No postoperative values were analyzed for patients cannulated
for ECMO while still in the operating room. Mean arterial pO2 was
calculated for the 4 hours before ECMO initiation for all ECMO cases
cannulated postoperatively and compared with the mean arterial pO2 of
the group of control patients for the first 48 hours postoperatively.
Surgical Practice and ECMO Decision Making
Shunt type was determined by surgeon preference throughout the study
period. Decision to cannulate for ECMO was made by the surgeon for
patients cannulated in the operating room and jointly by surgeon and
cardiac intensivist for patients cannulated in the cardiac intensive care
unit. Indications for ECMO were documented and included inability to
separate from cardiopulmonary bypass, hypoxia, hypotension/low cardiac
output, or cardiac arrest.
Statistical Analysis
Demographic and clinical characteristics were compared between cases
and controls using t-test or Wilcoxon rank-sum tests for continuous
variables and c2 tests or Fisher exact tests for categorical variables.
Unadjusted and adjusted odds ratios and their 95% confidence intervals
(CIs) were estimated using logistic regression to evaluate associations
between possible risk factors and the need for ECMO support before
hospital discharge after a Norwood operation. Variables associated with the
need for ECMO in the univariate analyses, with P  .1, were investigated
further by building multivariate models with the backward elimination
method. Optimal cutoffs for postoperative lactate and VIS for the prediction
of the need for ECMO were determined with the best combinations of
sensitivity and specificity using receiver-operating characteristic (ROC)
curves. The area under the curve (AUC), positive predictive value (PPV),
and negative predictive value (NPV) for each optimal cutoff were also
reported. All analyses were performed using SAS, version 9.2 (SAS Institute
Inc, Cary, NC), with statistical significance set at P<.05 using 2-sided tests.RESULTS
Among the 64 ECMO cases, indication for ECMO
was inability to wean from cardiopulmonary bypass in
18 patients (28.1%), hypotension or low cardiac output in
14 patients (21.9%), hypoxia in 23 patients (35.9%), andThe Journal of Thoracic and Cacardiac arrest in 9 patients (14.1%). Thirty-nine patients
(60.1%) were cannulated for ECMO before leaving the
operating room, and 53 patients (82.8%) were cannulated
on the day of surgery. Cases and controls were alike in
sex, race, and age at surgery (Table 1). Cases had a lower
mean birth weight than controls, and 15.6% of cases were
classified as low birth weight (<2.5 kg) compared with
8.4% of controls (P ¼ .1). Cases were less likely to have
a systemic left ventricle than were controls (1.6% vs
11%; P ¼ .02). Serum lactate before surgery was higher
in cases than controls (median, 1.5 [interquartile range
{IQR}, 1.2-1.8] vs 1.3 [IQR, 1.1-1.6]; P ¼ .01), whereas
there was no difference in preoperative serum blood urea
nitrogen or creatinine. Therewas no difference in the degree
of atrioventricular valve regurgitation on preoperative echo
between cases and controls. Cases were more likely to have
more than mildly depressed systolic function of the
systemic ventricle than were controls (12.5% vs 5.2%),
but this difference did not reach statistical significance
(P ¼ .09). Cases were significantly more likely to have an
ascending aorta of less than 2.0 mm than were controls
(25% vs 11%; P ¼ .01).
Most cases and controls underwent standard Norwood
operations, whereas 2 cases and 3 controls underwent
Damus-Kaye-Stansel anastomosis and systemic-PA shunt
placement without arch reconstruction (Table 1). Cardio-
pulmonary bypass (CPB) time was significantly longer for
cases than for controls (median, 133 [IQR, 109-181]
minutes vs 91 [IQR, 73-120] minutes; P< .0001). There
was no significant difference in aortic crossclamp time or
hypothermic circulatory arrest (HCA) time between groups.
There were 9 patients with an HCA time of 0 (1 case and 8
controls). Cases were significantly more likely than
controls to undergo shunt revision while in the operating
room (17.2% vs 6.3%; P ¼ .01). Cases were also more
likely to leave the operating room with a right ventricle
(RV)-PA conduit as a final shunt type as opposed to a
modified Blalock-Taussig shunt or central shunt
(P ¼ .04). Of the 18 RV-PA conduit patients who required
ECMO, 5 had been revised in the operating room from a
modified Blalock-Taussig shunt (2 because of hypotension,
1 because of hypoxia, and 2 because of both hypotension
and hypoxia). If these 5 patients were excluded from
analysis, RV-PA conduit was no longer associated with
the need for ECMO on univariate analysis (P ¼ .31).
Cases had a significantly higher peak lactate (median,
11.3 [IQR, 7.7-14.1] vs 5.7 [IQR, 4.2-7.5]; P<.0001) and
higher peak VIS (median, 35 [IQR, 23-43] vs 18.5 [IQR,
14-24]; P<.0001) within the first 48 hours postoperatively
compared with controls. There was no difference between
mean  SD arterial pO2 in the 4 hours before cannulation
for ECMO patients (36.7 7.9) and the mean SD arterial
pO2 over the first 48 hours postoperatively for control
patients (36.5  3.4) (P ¼ .90).rdiovascular Surgery c Volume 148, Number 1 267
TABLE 1. Comparison of demographic and clinical characteristics
between patients who do and do not require ECMO after a Norwood
operation (N ¼ 255)
Characteristics
Postoperative ECMO
P
value*
Yes
(n ¼ 64)
No
(n ¼ 191)
Male sex 41 (64.1) 124 (64.9) .90
Race
White 48 (75.0) 147 (77.0) .23
African American 10 (15.6) 17 (8.9)
Other/unknown 6 (9.4) 27 (14.1)
Age at stage 1 surgery, d 6 (5-8) 7 (5-8) .18
Birth weight, kg 3.1  0.6 3.3  0.5 .01
<2.5 kg 10 (15.6) 16 (8.4) .10
Cardiac diagnosis
Single right ventricle anatomy .02y
MS/AA 18 (28.1) 39 (20.4)
MA/AA 18 (28.1) 57 (29.8)
MS/AS 14 (21.9) 48 (25.1)
MA/AS 1 (1.6) 3 (1.6)
Unbalanced AVSD 8 (12.5) 14 (7.3)
DORV/HLV 4 (6.3) 9 (4.7)
Single left ventricle anatomy
TA/D-TGA 0 (0.0) 10 (5.2)
DILV 0 (0.0) 11 (5.8)
TA/NRGA/hypoplastic arch 1 (1.6) 0 (0.0)
Prematurity (<37 wk)
Yes 11 (17.2) 18 (9.4) .08
No 52 (81.3) 172 (90.1)
Missing 1 (1.6) 1 (0.5)
Extracardiac or genetic anomaly
Extracardiac 13 (20.3) 21 (11.0) .06
Chromosomal 3 (4.7) 8 (4.2) 1.00
Preoperative
Preoperative lactate (N ¼ 245) 1.5 (1.2-1.8) 1.3 (1.1-1.6) .01
2.0 11 (17.7) 21 (11.5) .21
Highest preoperative lactate
(N ¼ 245)
3.7 (2.4-5.0) 3.6 (2.6-5.1) .74
Preoperative BUN, mg/dL 20 (12-28) 20 (15-28) .72
Preoperative creatinine, mg/dL 0.6 (0.4-0.7) 0.5 (0.4-0.7) .49
Preoperative intervention on
atrial septum
6 (9.4) 9 (4.7) .22
Preoperative AVVR
None 20 (31.3) 42 (22.0) .91z
Trace to mild/mild 35 (54.7) 121 (63.4)
Mild to moderate/moderate 6 (9.4) 19 (9.9)
Moderate to severe/severe 3 (4.7) 9 (4.7)
Preoperative ventricular function
Normal 40 (62.5) 143 (74.9) .09x
Mildly depressed 16 (25.0) 38 (19.9)
Mild to moderate/moderately
depressed
7 (10.9) 8 (4.2)
Moderate to severe/severely
depressed
1 (1.6) 2 (1.0)
Aortic size, mm (N ¼ 223) 2.7 (1.8-4.7) 3.0 (2.1-4.6) .34
<2.0 mm (25th percentile) 16 (25.0) 21 (11.0) .01
2.0 mm 44 (68.8) 142 (74.3)
(Continued)
TABLE 1. Continued
Characteristics
Postoperative ECMO
P
value*
Yes
(n ¼ 64)
No
(n ¼ 191)
Intraoperative
Type of stage 1 surgery
Norwood 62 (96.9) 188 (98.4) .60
DKS þ shunt 2 (3.1) 3 (1.6)
CPB time, min 133 (109-181) 91 (73-120)<.0001
ACC time, min 43 (36-48.5) 39 (35-46) .19
HCA time, min 39 (33.5-44) 36 (31-43) .10
Shunt revision 11 (17.2) 12 (6.3) .01
Final shunt type Blalock-Tausig 40 (62.5) 149 (78.0) .04k
Central 6 (9.4) 11 (5.8)
RV-to-PA/Sano 18 (28.1) 31 (16.2)
Postoperative
Highest postoperative lactate
within 48 h of surgery
(N ¼ 213){
11.3 (7.7-14.1) 5.7 (4.2-7.5)<.0001
Maximum postoperative VIS
within 48 h of surgery
(N ¼ 204)#
35 (23-43) 18.5 (14-24) <.0001
Data are presented as number (%) for categorical variables and mean SD or median
(25th percentile-75th percentile) for continuous variables. ECMO, Extracorporeal
membrane oxygenation; MS/AA, mitral stenosis/aortic atresia; MA/AA, mitral
atresia/aortic atresia; MS/AS, mitral stenosis/aortic stenosis; MA/AS, mitral atresia/
aortic stenosis; AVSD, atrioventricular septal defect; DORV/HLV, double-outlet right
ventricle/hypoplastic left ventricle; TA/D-TGA, tricuspid atresia/dextrotransposition
of the great arteries; DILV, double-inlet left ventricle; NRGA, normally related great
arteries; BUN, blood urea nitrogen; AVVR, atrioventricular valve regurgitation;
DKS, Damus-Kaye-Stansel; CPB, cardiopulmonary bypass; ACC, aortic crossclamp;
HCA, hypothermic circulatory arrest; RV, right ventricle; PA, pulmonary artery; VIS,
vasoactive inotropic score. *P value from c2 tests or Fisher exact tests for categorical
variables, Mantel-Haenszel c2 tests for ordinal variables, and t-test or Wilcoxon
rank-sum tests for continuous variables on comparison of each characteristic between
the patients with/without need for postoperative ECMO. yComparison made as single
right ventricle versus single left ventricle and the corresponding P value from c2 test.
zComparison of none/trace to mild/mild versus mild to moderate/moderate/moderate
to severe/severe and P value from c2 test. xComparison of normal/mildly depressed
versus mild to moderate/moderate/moderate to severe/severely depressed and the
corresponding P value from Fisher exact test. kComparison made as modified
Blalock-Tausig shunt or central shunt versus RV-PA conduit and the corresponding
P value from c2 test. {A total of 42 patients (16.5%) with missing data (38 cases
[not collected after cannulation in the operating room] and 4 controls). #A total of
51 patients (20%) with missing data (41 cases [not collected after cannulation in
the operating room] and 10 controls).
Congenital Heart Disease Friedland-Little et al
268 The Journal of Thoracic and Cardiovascular Surg
C
H
DBy univariate analysis, risk factors for requiring ECMO
included higher preoperative lactate, ascending aorta less
than 2.0 mm, longer CPB time, requirement for intraopera-
tive shunt revision, and placement of an RV to PA shunt
(Table 2). A systemic left ventricle was protective against
the need for postoperative ECMO. Several preoperative
variables, including low birth weight, prematurity, the pres-
ence of extracardiac anomalies, and more than mildly
depressed systemic ventricular function on preoperative
echo appeared to be associated with the need for ECMO,
with an OR of 2 or greater and P values of  .1; these vari-
ables were, therefore, included in the multivariate model.
Multivariate logistic regression analysis revealed that
low birth weight (adjusted odds ratio [AOR], 2.47; 95%ery c July 2014
TABLE 2. Unadjusted odds of requiring ECMO after a Norwood
operation (N ¼ 255)
Characteristics OR
95% CI of OR
(lower, upper) P value*
Birth weight, kg
<2.5 2.03 0.87, 4.72 .10
2.5 Ref
Single-ventricle morphology
Hypoplastic right ventricle 0.13 0.02, 0.97 .02
Hypoplastic left ventricle Ref
Prematurity (<37 wk) 2.02 0.90, 4.55 .08
Extracardiac anomaly 2.06 0.97, 4.41 .06
Preoperative lactate, mmol/L 1.97 1.15, 3.38 .01
Preoperative ventricular
function
More thanmildly depressed 2.57 0.84, 7.65 .09
Normal or mildly depressed Ref
Aortic size, mm
<2.0 2.46 1.18, 5.12 .01
2.0 Ref
CPB time, min 1.01 1.01, 1.02 <.0001
Shunt revision 3.09 1.29, 7.41 .01
Final shunt type
Blalock-Tausig or central Ref .04
RV-to-PA/Sano 2.02 1.04, 3.94
ECMO, Extracorporeal membrane oxygenation; OR, (unadjusted) odds ratio;
CI, confidence interval; Ref, reference category; CPB, cardiopulmonary bypass;
RV, right ventricle; PA, pulmonary artery. *P value from (unadjusted) logistic
regression model.
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DCI, 1.02-6.00; P ¼ .045) and longer CPB time (AOR, 1.01
for each minute of CPB; 95% CI, 1.01-1.02; P< .0001)
were independently associated with the need for postopera-
tive ECMO (Table 3).
Receiver-operating characteristic curve analysis of peak
lactates within 48 hours of surgery revealed that a cutoff
of 9 mmol/L was most predictive of requiring ECMO,
with a sensitivity of 69.2% and a specificity of 86.6%
(OR, 14.6; 95% CI, 5.7-37.1; P< .0001) (Figure 1). A
lactate level greater than 9 had a PPVof 41.9% for requiring
ECMO, whereas a lactate level less than 9 had an NPV of
95.3%. Similarly, a VIS of 27 within 48 hours of surgery
was most prognostic, with a sensitivity of 73.9% and a
specificity of 82.3% for identifying patients who wouldTABLE 3. Adjusted odds of requiring ECMO after a Norwood
operation (N ¼ 255)
Characteristics AOR
95% CI of AOR
(lower, upper) P value*
Birth weight, kg
<2.5 2.47 1.02, 6.00 .045
2.5 Ref
CPB time, min 1.01 1.01, 1.02 <.0001
ECMO, Extracorporeal membrane oxygenation; AOR, adjusted odds ratio; CI, confi-
dence interval;Ref, reference category;CPB, cardiopulmonary bypass. *P value from
multivariable logistic regression model.
The Journal of Thoracic and Carequire ECMO (OR, 13.2; 95% CI, 4.8-36.1; P< .0001)
(Figure 2). A peak VIS of greater than 27 had a PPV of
34.7% for requiring ECMO, whereas a VIS of less than
27 had an NPVof 96.1% for requiring ECMO.
DISCUSSION
Short- and mid-term outcomes for patients requiring
ECMO support after a Norwood operation are poor,1-4,6
and ECMO is an independent risk factor for 30-day and
hospital mortality post-Norwood.4 Despite this, there are
little data on risk factors for requiring ECMO in this setting.
A recent analysis of data from the Pediatric Heart Network
Single-Ventricle Reconstruction (SVR) trial identified birth
weight lower than 2.5 kg and additional operations after the
Norwood as risk factors for requiring ECMO, whereas
greater age at Norwood operation appeared to be protective
against the need for ECMO.4 In the SVR data set, patients
with mitral stenosis and aortic atresia were more likely to
require ECMO intraoperatively than were patients with
other anatomic features.4 These are the only data available
regarding risk factors for ECMO after a Norwood
operation.
In our retrospective study, we have identified several
characteristics associated with requiring ECMO after a
Norwood operation, including 2 variables (birth weight
<2.5 kg and longer CPB time) that were independently
associated with the need for ECMO in multivariate logistic
regression analysis. Of these 2 variables, only longer CPB
time is potentially modifiable. Although CPB time is likely
significantly related to intrinsic anatomic features, there is
presumably a correlation with surgeon volume and
technique as well. Surgeon volume has been previously
correlated with morbidity and mortality after a Norwood
operation,4,7 although other data have indicated that
center volume may be more important.8,9 Our data
suggest that if surgeon experience or technique does
affect CPB time, this may also modify the risk of
postoperative ECMO. Interestingly, there were no
significant differences in crossclamp time or HCA time
between groups. This suggests that difficulty with the arch
reconstruction was not the primary reason for prolonged
CPB time in patients requiring ECMO.
Shunt revision was more common in cases than controls,
and time spent revising a shunt was likely a significant
contributor to the longer CPB times in the ECMO cases.
Of ECMO cases in our series, 28% were unable to wean
from bypass, and time spent trying to separate from bypass
and then waiting for an ECMO circuit likely also contrib-
uted to longer CPB time. The possibility that the patients
unable to wean from bypass may constitute a unique group,
and that the prolonged CPB times for this group may have
explained the correlation between CPB time and risk for
ECMO in the overall cohort, was considered. Preoperative
characteristics and intraoperative data were comparedrdiovascular Surgery c Volume 148, Number 1 269
FIGURE 1. Distribution (A) and receiver-operating characteristic curve (B) of peak serum lactate within 48 hours of surgery. Lactate cutoff of 9 mmol/L
had optimal sensitivity (69.2%) and specificity (86.6%) for requirement of extracorporeal membrane oxygenation (ECMO). PPV, Positive predictive value;
NPV, negative predictive value; AUC, area under the curve.
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Dbetween the patients unable to wean from bypass and the
rest of the ECMO cases, and no significant differences
between groups were identified.
Along with CPB time, low birth weight (LBW; weight
<2.5 kg) was the other variable independently associated
with the need for ECMO in our analysis. This result is
consistent with the recent SVR data identifying LBW as
a risk factor for ECMO post-Norwood and emphasizes
that LBW, well established as a risk factor for early
mortality after a Norwood operation,4,10,11 is also
significantly correlated with the need for ECMO in the
postoperative period. The overlap between variables
associated with the need for ECMO in our analysis and
the list of previously published risk factors for mortality
post-Norwood was a striking feature of our data. In
addition to LBW and longer CPB time, nearly all of theFIGURE 2. Distribution (A) and receiver-operating characteristic curve (B) of
of 27 had optimal sensitivity (73.9%) and specificity (82.3%) for requirement o
value; NPV, negative predictive value; AUC, area under the curve.
270 The Journal of Thoracic and Cardiovascular Surgvariables associated with the need for ECMO in our uni-
variate analysis (higher lactate, prematurity, extracardiac
anomalies, ascending aorta <2.0 mm, systemic right
ventricle, and more than mildly depressed systemic
ventricular function) have previously been identified as
risk factors for early mortality after a Norwood opera-
tion.4,10-16 Rather than identifying any unique
characteristics that place patients at risk for requiring
ECMO, these data emphasize the fact that the patients
who ultimately require ECMO after a Norwood
operation are the same patients who are known to face
increased risk of mortality after a Norwood. ECMO has
been previously identified as an independent risk factor
for mortality after a Norwood operation,4 but as is sug-
gested by the overlap of risk factors, ECMO is more likely
a marker of severity of illness than a true cause of death.peak vasoactive inotrope score (VIS) within 48 hours of surgery. VIS cutoff
f extracorporeal membrane oxygenation (ECMO). PPV, Positive predictive
ery c July 2014
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DIn addition to our analysis of preoperative and intra-
operative risk factors associated with the need for ECMO
post-Norwood, we also aimed to assess the prognostic value
of 3 postoperative parameters (serum lactate, VIS, and pO2)
in estimating the likelihood of requiring ECMO. Although
arterial pO2 did not appear to be associated with risk of
ECMO, both peak serum lactate and peak VIS appeared
to have some predictive value. Serum lactate level is a
marker for adequacy of systemic oxygen delivery,17,18 and
both elevated lactate19,20 and rapid increase in lactate21
have been correlated with poor outcomes after congenital
heart surgery. Recently, Murtuza and colleagues15 reported
that the inability to clear blood lactate to less than 6.76
mmol/L within 24 hours of a Norwood operation was highly
predictive of early mortality. Our ROC analysis identified a
lactate of 9 mmol/L as most predictive of the need for
ECMO, with a PPV of 41.9% and an NPV of 95.3%
(AUC, 0.83) (Figure 1). VIS has also been previously
used as a marker of illness severity after congenital heart
surgery, and has been shown to correlate with poor
outcomes.5,22 In our cohort, ROC analysis identified a
VIS of 27 as most predictive of the need for ECMO, with
a PPV of 34.7% and an NPV of 96.1% (AUC, 0.83)
(Figure 2). Both AUC values suggest good discriminative
ability, and although the positive predictive value for each
variable is limited, the high negative predictive values
indicate that a lactate cutoff of 9 mmol/L and a VIS cutoff
of 27 are useful in identifying patients at low risk for
requiring ECMO post-Norwood.
The optimal management of the ‘‘high-risk’’ single-
ventricle patient, with one or more of the shared risk
factors for ECMO and mortality, is not well established.
Checchia and colleagues23 have reported improved Nor-
wood outcomes and unchanged transplant outcomes by
risk-stratifying hypoplastic left heart syndrome (HLHS)
patients preoperatively, and recommending primary heart
transplantation to patients believed to be high risk. A recent
multicenter study described 71% overall survival at 1 year
for infants with unpalliated HLHS who undergo heart trans-
plantation,24 although outcomes of primary heart transplan-
tation in HLHS patients with LBWor other risk factors have
not been established. Hybrid stage 1 palliation, consisting of
bilateral banding of the pulmonary arteries, ductal stenting,
and atrial septostomy, has also been used as an alternative for
high-risk patients with HLHS and variants. Preliminary re-
sults have been mixed, with one small series reporting no
survival benefit at all compared with standard Norwood,25
and others reporting improved early survival with evidence
of persistent mortality risk before and after comprehensive
stage 2.26,27 Rather than considering alternative surgical
strategies, other centers have attempted to improve
outcomes in high-risk single-ventricle patients by
modifying postoperative management. Ghanayem and col-
leagues28 reported improved early post-Norwood survivalThe Journal of Thoracic and Cafor high-risk patients (LBW, premature, or extracardiac
anomalies) through the use of intensive monitoring,
including venous oximetry and near-infrared spectroscopy.
Given the lack of clarity regarding the optimal manage-
ment of patients at increased risk for ECMO and mortality
post-Norwood, the data presented herein do not provide any
clear guidance for preoperative or postoperative care for the
patients with the risk factors we have identified. Our data
do, however, offer additional insight into the characteristics
that make a patient high risk. This information is valuable
both for identifying appropriate patients for trials of
alternative therapies and for providing accurate counseling
and prognostication to patient families.
There were several limitations to our study. As with most
retrospective medical record reviews, not all data were
available for every patient, although overall, the integrity
of the data set was good, with only one preoperative or
intraoperative variable (aortic size) being missing in greater
than 5% of patients. Postoperative data were not collected
for the approximately 60% of ECMO patients cannulated
in the operating room, however, so although VIS and peak
lactate did seem to correlate with risk of ECMO, these
parameters were not included in multivariable models. A
sensitivity analysis was performed comparing patients
with and without missing postoperative lactate or VIS
data and revealed no differences between groups other
than race, with African Americans having more missing
lactate and VIS data (40.7%) than whites (19.5%)
(P ¼ .01). Another limitation of this study was the fact
that the threshold to cannulate for ECMO likely varied
depending on the surgeon and cardiac intensivist involved.
Although ECMO is generally not used ‘‘electively’’ at our
institution, we were unable to account for any differences
in the degree of postoperative hypoxia, hypotension, or
acidosis that may have been considered acceptable by
different practitioners. Finally, the relatively small cohort
size limited our ability to detect differences between groups
and to perform any subgroup analyses.CONCLUSIONS
LBWand longer CPB time are independently associated
with the need for ECMO after a Norwood operation. The
patients who are likely to require ECMO post-Norwood
share many characteristics with the patients at risk for early
mortality post-Norwood. The optimal management strategy
for this high-risk subset of single-ventricle patients has yet
to be adequately established. Peak serum lactate and VIS
appear to have some prognostic value regarding the
potential need for ECMO in the early postoperative period.References
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